Alzheimer’s breakthrough: FDA approves new treatment targeting brain plaque
Alzheimer’s breakthrough: FDA approves new treatment targeting brain plaque A new Alzheimer’s drug, Lecanemab, targets brain plaque, showing promise in slowing cognitive decline. Next up in 5 Backlash after federal…